89R13930 AND-D
By: Menéndez S.B. No. 2470
A BILL TO BE ENTITLED
AN ACT
relating to the requirements for the labeling and dispensing of a
prescription drug or biological product.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 562.006, Occupations Code, is amended by
amending Subsections (b) and (f) and adding Subsection (g) to read
as follows:
(b) In addition to the information required by Subsection
(a), the label on the dispensing container of a drug or biological
product dispensed by a Class A or Class E pharmacy must [indicate]:
(1) indicate:
(A) the name, address, and telephone number of
the pharmacy;
(B) [(2)] the date the prescription is
dispensed;
(C) [(3)] the name of the prescribing
practitioner;
(D) [(4)] the name of the patient or, if the drug
or biological product was prescribed for an animal, the species of
the animal and the name of the owner;
(E) [(5)] instructions for use;
(F) [(6)] the quantity dispensed;
(G) [(7)] if the drug or biological product is
dispensed in a container other than the manufacturer's original
container, the date after which the prescription should not be
used, determined according to criteria established by board rule
based on standards in the United States Pharmacopeia-National
Formulary; and
(H) [(8)] any other information required by
board rule; and
(2) include, in a format accessible to the patient
through a mobile Internet application or assistive technology
electronic device available to the patient at no cost, the
information described by Subdivision (1) and information regarding
potential side effects and contraindicated medications.
(f) The [board shall adopt rules requiring the] label on a
dispensing container must [to] be in plain language and printed in
Times New Roman with a minimum of 12-point [an easily readable] font
size [for the consumer].
(g) A pharmacist at a Class A or Class E pharmacy shall, on a
patient's request, provide to the patient a large-print data sheet
containing:
(1) the information required under Subsection (b)(1)
to be on the label on a dispensing container of a drug or biological
product dispensed to the patient; and
(2) information regarding potential side effects and
contraindicated medications for the drug or biological product
dispensed to the patient.
SECTION 2. Not later than January 1, 2026, the Texas State
Board of Pharmacy shall adopt any rules necessary to implement the
changes in law made by this Act.
SECTION 3. The changes in law made by this Act apply only to
a drug or biological product dispensed on or after March 1, 2026. A
drug or biological product dispensed before March 1, 2026, is
governed by the law in effect immediately before the effective date
of this Act, and the former law is continued in effect for that
purpose.
SECTION 4. This Act takes effect September 1, 2025.